For research use only. Not for therapeutic Use.
NAI-N3 (Cat No.:I013208) is a potent small molecule inhibitor known for its ability to target specific viral and cellular processes. It is primarily studied for its activity against viral proteases, particularly in the context of HIV and other viral infections. By inhibiting the replication of viruses, NAI-N3 may reduce viral load and improve outcomes in infected individuals. In addition to its antiviral properties, it is being explored for potential applications in cancer therapy, as it can disrupt cellular signaling pathways involved in tumor progression. Ongoing research aims to evaluate its safety and efficacy.
Catalog Number | I013208 |
CAS Number | 1612756-29-2 |
Molecular Formula | C₁₀H₈N₆O |
Purity | ≥95% |
Target | Others |
Solubility | DMSO: ≥115 mg/mL; H2O: 1 mg/mL (Need ultrasonic and warming) |
IUPAC Name | [2-(azidomethyl)pyridin-3-yl]-imidazol-1-ylmethanone |
InChI | InChI=1S/C10H8N6O/c11-15-14-6-9-8(2-1-3-13-9)10(17)16-5-4-12-7-16/h1-5,7H,6H2 |
InChIKey | QPSQVTFTPHUCEH-UHFFFAOYSA-N |
SMILES | C1=CC(=C(N=C1)CN=[N+]=[N-])C(=O)N2C=CN=C2 |
Reference | [1]. Flynn RA, et al. Transcriptome-wide interrogation of RNA secondary structure in living cells with icSHAPE. Nat Protoc. 2016 Feb;11(2):273-90. |